Reducing Adult Inpatients Anxiety With Virtual Reality Meditation
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of the study is to evaluate if non-invasive, distracting devices (virtual reality) can decrease anxiety and improve affect and satisfaction in adult, hospitalized patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable anxiety
Started Jun 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2024
CompletedFirst Posted
Study publicly available on registry
January 31, 2024
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
Study Completion
Last participant's last visit for all outcomes
May 31, 2027
May 16, 2025
May 1, 2025
12 months
January 22, 2024
May 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Hospital Anxiety and Depression Scale (HADS)
Hospital Anxiety and Depression Scale (HADS) questionnaire. The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.
Before and Immediate after intervention
Study Arms (2)
Virtual Reality
EXPERIMENTALParticipants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Control
NO INTERVENTIONNo intervention (i.e. virtual reality headset) will be applied to the participant.
Interventions
Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Eligibility Criteria
You may qualify if:
- between age 18-99
- hospitalized at Stanford Health Care
- english-speaking
You may not qualify if:
- significant cognitive impairment or inability to consent
- current nausea
- visual problems or currently using corrective glasses that are incompatible with the virtual reality headset
- a history of severe motion sickness
- a history of seizures cause by flashing light
- clinically unstable or require immediate/urgent intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Health Care (SHC)
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Thomas Caruso
Stanford University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
January 22, 2024
First Posted
January 31, 2024
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
May 31, 2027
Last Updated
May 16, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share